# Database Certification

## Executive Summary
The Prisma schema is valid and the application uses transactions for the critical clinical mutations. The current evidence supports staging readiness, but not full enterprise production certification without a real database environment and targeted query profiling.

## Findings
- The schema validates successfully.
- Core mutations that change stock, prescription, diagnosis, and audit state are transaction-backed.
- No new indexes were introduced because there was no production query evidence to justify them.

## Evidence
- Verified with: npx prisma validate
- Verified with: npx prisma generate

## Risk Level
Medium

## Critical Issues
- No explain-plan or slow-query profiling was executed against a representative dataset.
- No real production-scale database concurrency test was executed.

## Recommendations
- Profile the top clinical queries in staging.
- Add explain-plan review for appointment, queue, and prescription queries.

## Pass / Fail
Pass for schema validity; Not Executed for production-scale query profiling.
